Literature DB >> 20446725

Effect of heparin oligomer chain length on the activation of valvular interstitial cells.

Sara Pedron1, Andrea M Kasko, Carmen Peinado, Kristi S Anseth.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20446725      PMCID： PMC2896009          DOI： 10.1021/bm100211k

Source DB:  PubMed          Journal:  Biomacromolecules        ISSN： 1525-7797            Impact factor:   6.988


× No keyword cloud information.
  40 in total

1.  Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization.

Authors:  J Schlessinger; A N Plotnikov; O A Ibrahimi; A V Eliseenkova; B K Yeh; A Yayon; R J Linhardt; M Mohammadi
Journal:  Mol Cell       Date:  2000-09       Impact factor: 17.970

2.  Compositional analysis of heparin/heparan sulfate interacting with fibroblast growth factor.fibroblast growth factor receptor complexes.

Authors:  Fuming Zhang; Zhenqing Zhang; Xinfu Lin; Andrew Beenken; Anna V Eliseenkova; Moosa Mohammadi; Robert J Linhardt
Journal:  Biochemistry       Date:  2009-09-08       Impact factor: 3.162

3.  Using a 3-O-sulfated heparin octasaccharide to inhibit the entry of herpes simplex virus type 1.

Authors:  Ronald Copeland; Arun Balasubramaniam; Vaibhav Tiwari; Fuming Zhang; Arlene Bridges; Robert J Linhardt; Deepak Shukla; Jian Liu
Journal:  Biochemistry       Date:  2008-05-06       Impact factor: 3.162

4.  Regulation of valvular interstitial cell calcification by components of the extracellular matrix.

Authors:  Karien J Rodriguez; Kristyn S Masters
Journal:  J Biomed Mater Res A       Date:  2009-09-15       Impact factor: 4.396

5.  The effects of heparin releasing hydrogels on vascular smooth muscle cell phenotype.

Authors:  Jeffrey A Beamish; Leah C Geyer; Nada A Haq-Siddiqi; Kandice Kottke-Marchant; Roger E Marchant
Journal:  Biomaterials       Date:  2009-08-26       Impact factor: 12.479

6.  Minimum FGF2 binding structural requirements of heparin and heparan sulfate oligosaccharides as determined by NMR spectroscopy.

Authors:  Sara Guglier; Milos Hricovíni; Rahul Raman; Laura Polito; Giangiacomo Torri; Benito Casu; Ram Sasisekharan; Marco Guerrini
Journal:  Biochemistry       Date:  2008-12-30       Impact factor: 3.162

7.  Modulation of TGFbeta1-dependent myofibroblast differentiation by hyaluronan.

Authors:  Jason Webber; Robert H Jenkins; Soma Meran; Aled Phillips; Robert Steadman
Journal:  Am J Pathol       Date:  2009-06-18       Impact factor: 4.307

8.  Specific inhibition of FGF-2 signaling with 2-O-sulfated octasaccharides of heparan sulfate.

Authors:  Satoko Ashikari-Hada; Hiroko Habuchi; Noriko Sugaya; Takashi Kobayashi; Koji Kimata
Journal:  Glycobiology       Date:  2009-03-02       Impact factor: 4.313

9.  The fibronectin domain ED-A is crucial for myofibroblastic phenotype induction by transforming growth factor-beta1.

Authors:  G Serini; M L Bochaton-Piallat; P Ropraz; A Geinoz; L Borsi; L Zardi; G Gabbiani
Journal:  J Cell Biol       Date:  1998-08-10       Impact factor: 10.539

10.  Fibroblast growth factor represses Smad-mediated myofibroblast activation in aortic valvular interstitial cells.

Authors:  Melinda C Cushing; Peter D Mariner; Jo-Tsu Liao; Evan A Sims; Kristi S Anseth
Journal:  FASEB J       Date:  2008-01-24       Impact factor: 5.191
View more
  3 in total

1.  Rapid 3D printing of anatomically accurate and mechanically heterogeneous aortic valve hydrogel scaffolds.

Authors:  L A Hockaday; K H Kang; N W Colangelo; P Y C Cheung; B Duan; E Malone; J Wu; L N Girardi; L J Bonassar; H Lipson; C C Chu; J T Butcher
Journal:  Biofabrication       Date:  2012-08-23       Impact factor: 9.954

Review 2.  Application of hydrogels in heart valve tissue engineering.

Authors:  Xing Zhang; Bin Xu; Daniel S Puperi; Yan Wu; Jennifer L West; K Jane Grande-Allen
Journal:  J Long Term Eff Med Implants       Date:  2015

3.  Heparan sulfate hexasaccharide selectively inhibits cancer stem cells self-renewal by activating p38 MAP kinase.

Authors:  Nirmita J Patel; Chetna Sharon; Somesh Baranwal; Rio S Boothello; Umesh R Desai; Bhaumik B Patel
Journal:  Oncotarget       Date:  2016-12-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.